Fouad Ghazi Souki

Fouad Ghazi Souki

Auto-generated profile, based on publicly available information

Fouad Ghazi Souki

Department of Anesthesiology, University of Miami, Jackson Memorial Hospital, Miami, FL, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2009 in Anesthesia & Analgesia
Verified
Journal Article
Closed access
MAMarie T. Aouad
Marie T. Aouad
AAAchir A. Al-Alami
Achir A. Al-Alami
VNViviane G. Nasr
Viviane G. Nasr
FSFouad G. Souki
Fouad G. Souki
RZReine A. Zbeidy
Reine A. Zbeidy
SSSahar M. Siddik-Sayyid
Sahar M. Siddik-Sayyid
Emergence from general anesthesia can be associated with coughing, agitation, and hemodynamic disturbances. Remifentanil may attenuate these responses. In a prospective, double-blind, randomized trial, we enrolled 60 adult patients undergoing nasal surgery using remifentanil-based anesthesia. During the emergence phase, the remifentanil group had remifentanil reduced to one tenth of the maintenance rate, whereas the control group had remifentanil discontinued. Times to awakening and tracheal extubation were similar between the two groups. During emergence, the remifentanil group (infusion rate 0.014 +/- 0.011 microg x kg(-1) x min(-1)) had a significantly lower incidence (40% vs 80%, P = 0.002) and less severe coughing compared with the control group, as well as a lower incidence of nonpurposeful movement (3.3% vs 30%, P = 0.006) and slower heart rates. Low-dose remifentanil during emergence did not prolong wake-up but reduced the incidence and severity of coughing from the endotracheal tube.

18 January 2018 in Current Urology Reports
Verified
Journal Article
Closed access
PDF file
GNGeorges Nasrallah
Georges Nasrallah
FSFouad G. Souki
Fouad G. Souki

21 August 2018 in BMC Anesthesiology
Verified
Journal Article
Open access
PDF file
FSFouad G. Souki
Fouad G. Souki
YRYiliam F. Rodriguez-Blanco
Yiliam F. Rodriguez-Blanco
SPSravankumar Reddy Polu
Sravankumar Reddy Polu
SEScott Eber
Scott Eber
KCKeith A. Candiotti
Keith A. Candiotti
Steep Trendelenburg during surgery has been associated with many position-related injuries. The American Society of Anesthesiology practice advisory recommends documentation, frequent position checks, avoiding shoulder braces, and limiting abduction of upper extremities to avoid brachial plexopathy. We conducted a web-based survey to assess anesthesiologists’ practices, institutional policies, and complications encountered when using steep Trendelenburg. Two thousand fifty randomly selected active members of the American Society of Anesthesiology were invited via email to participate in a 9-item web-based survey. Results are reported as absolute numbers and proportions with 95% confidence interval (CI). Survey response rate was 290 of 2050 (14.1%). 44.6% (95% CI, 38.9–50.3) of the respondents documented anesthesia start and finish, 73.9% (95% CI, 68.8–79) frequently checked positioning during surgery, 30.8% (95% CI, 25.4–36.2) reported using shoulder braces, 66.9% (95% CI, 61.5–72.3) tucked patients’ arms to the side, 54.0% (95% CI, 48.2–59.8) limited fluid administration, and more than two-thirds did not limit the duration or inclination angle. Notably, 63/290 (21.7%) reported a complication and only 6/289 (2.1%) had an institutional policy. The most common complication was airway and face edema, second was brachial plexus injury, and third was corneal abrasions. Most institutional policies, when present, focused on limiting duration of steep Trendelenburg and communication with surgical team. Only 1/6 policies required avoiding use of shoulder braces. Based on survey results, practices related to steep Trendelenburg varied among USA anesthesiologists. Differences included protective measures, documentation, positioning techniques, fluid management, and institutional guidelines. The singular commonality found among all respondents was lack of institutional policies. Survey results highlighted the need for institutional policies and more education.

14 January 2020 in Annals of Surgery
Verified
Journal Article
Closed access
NBNicolas A. Brozzi
Nicolas A. Brozzi
MLMatthias Loebe
Matthias Loebe
FSFouad Ghazi Souki
Fouad Ghazi Souki
TBThiago Beduschi
Thiago Beduschi
AGAli Ghodzisad
Ali Ghodzisad
RVRodrigo M. Vianna
Rodrigo M. Vianna
Introduction: Complexity of combined heart–liver transplantation has resulted in low adoption rates. We report a case series of adult patients receiving en-bloc heart–liver transplantation (HLTx), describe technical aspects, and discuss benefits of the technique. Methods: Retrospective review of patients receiving en-bloc HLTx over 18 months, with clinical follow up to 1 year. Primary outcomes included postoperative mortality and major complications. Secondary outcomes included 1-year survival, cardiac or hepatic allograft rejection, and infection. Results: Five patients received en-bloc HLTx. Mean recipient age was 43 years (26–63), and 3 patients were male. Total operative time was 430 minutes (393–480), cold and warm ischemic times of 85 (32–136) and 37.5 (31–47) minutes. Hospital survival was 80%. One patient died on postoperative day 55 due to fungal sepsis. Major postoperative complications included prolonged mechanical ventilation in 2 of 5 patients (40%), and renal insufficiency requiring hemodialysis in 2 of 5 patients (40%). Among patients discharged from hospital 1-year survival was 100%, with no evidence of rejection or infectious complications. Conclusion: En-bloc HLTx technique is a safe and effective strategy, decreasing operative times, and allograft ischemic times, whereas offering protection of implanted allografts during early stages of reperfusion while patient is hemodynamically supported on cardiopulmonary bypass.

22 May 2018 in Transplant International
Verified
Journal Article
Closed access
PDF file
YRYehuda Raveh
Yehuda Raveh
YRYiliam Rodriguez
Yiliam Rodriguez
EPErnesto Pretto
Ernesto Pretto
FSFouad Souki
Fouad Souki
VSVadim Shatz
Vadim Shatz
RNRamona Nicolau-Raducu
Ramona Nicolau-Raducu
This study describes the risk of thrombotic and hemorrhagic complications, both intraoperatively, and up to 1‐month following visceral transplantation. Data from 48 adult visceral transplants performed between 2010‐2017 were retrospectively studied (32 multivisceral (MVTx); 10 isolated intestine; 6 modified‐MVTx). Intraoperatively, intracardiac thrombosis (ICT)/pulmonary embolism (PE) occurred in 25%, 0% and 0% of MVTx, isolated intestine and modified MVTx, respectively, and was associated with 50% (4/8) mortality. Preoperative portal vein thrombosis (PVT) was a significant risk factor for ICT/PE (P=0.0073). Thromboeleastography resembling disseminated intravascular coagulation (DIC) (r time < 4mm combined with fibrinolysis or flat‐line) were statistically associated with occurrence of ICT/PE (P<0.0001). Compared to subgroup without ICT/PE, occurrence of ICT/PE was associated with an increased demand for all blood product components both overall, and each surgical stage. Hyperfibrinolysis (56%) was identified as cause of bleeding in MVTx. Incidence of postoperative thrombotic event at 1 month was 25%, 30% and 17% for MVTx, isolated intestine and modified MVTx, respectively. Incidence of postoperative bleeding complications at 1‐months was 11%, 20% and 17% for MVTx, isolated intestine and modified MVTx. In conclusion, MVTx recipients with preoperative PVT are at an increased risk of developing intraoperative life‐threatening ICT/PE events associated with DIC‐like coagulopathy.

8 May 2019 in Seminars in Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
PDF file
YRYehuda Raveh
Yehuda Raveh
FSFouad Souki
Fouad Souki
JLJoshua Livingstone
Joshua Livingstone
TBThiago Beduschi
Thiago Beduschi
RVRodrigo Vianna
Rodrigo Vianna
RNRamona Nicolau-Raducu
Ramona Nicolau-Raducu
Background and Objective. End-stage liver disease is characterized by a precarious imbalance of hemostasis. Detrimental consequences of hypofibrinolysis, also known as fibrinolytic shutdown, have been recently demonstrated, and its significance in visceral (ie, an allograft that contains the intestine) transplant remains unknown. Design and Setting. To fill this gap, following institutional review board approval, this retrospective study included 49 adult recipients of visceral allografts (14 “visceral allograft without the liver” and 35 “multivisceral” with the liver) transplanted between 2010 and 2018 in a single university hospital, and for whom pre-incisional thromboelastography was available. Based on percent clot lysis 30 minutes after maximal amplitude, patients were stratified into 3 fibrinolysis phenotypes: fibrinolytic shutdown, physiologic fibrinolysis, and hyperfibrinolysis. Results. Fibrinolytic shutdown occurred in 57% of patients, with higher incidence in recipients of multivisceral transplant (69%) compared with visceral allograft without liver (29%) allografts ( P = .04). Fibrinolytic shutdown was associated with an increase in both intraoperative thrombosis and hemorrhage. Intraoperative thrombosis (18%) occurred only with multivisceral transplant, and accounted for 36% of in-hospital mortality. A clinically meaningful reduction in incidence of intraoperative thrombosis was noted in recipients who received intravenous heparin thromboprophylaxis. Logistic regression identified pretransplant platelet count as a risk factor for fibrinolytic shutdown (odds ratio = 0.992, 95% confidence interval = [0.984-0.998]; χ2 = 7.8, P = .005). Conclusions. This study highlights fibrinolytic shutdown as a dominant and clinically important feature of the hemostatic imbalance in recipients undergoing visceral transplantation.